USP’s Healthcare Quality Expert Committee has released draft Medicare Model Guidelines version 7.0 for public comment. Comment deadline is November 2, 2016.
Per the Medicare Modernization Act, USP’s expert volunteers and staff work with pharmaceutical benefit managers and others to develop drug categories and classes that prescription drug plans may use to develop Medicare Part D formularies. These periodic revisions also help the Guidelines keep pace with changes to the way covered Part D drugs are used.
As part of their draft process, the committee encourages public review and comment. Those comments are taken into consideration—and may help to inform important revisions—as the committee finalizes its submission to the Centers for Medicare and Medicaid Services.